Scientists in Germany claim to have made a nasal vaccine that can stop Covid-19 infections in the nose and throat.
In hamster experiments, two doses of this live but weakened vaccine stopped the virus from copying itself in the animals' upper airways, resulting in "sterilizing immunity" and preventing illness, a long-sought goal during the pandemic.
This breakthrough comes as other nasal vaccines are being tested in clinical trials or have already reached late-stage testing. However, experts caution that more work is needed before this vaccine can be widely used.
China and India have recently rolled out nasal vaccines given through the nasal tissues, but effectiveness data for these has not been published, leaving it unclear how well they may actually be working.
To combat the virus, researchers are focusing on boosting mucosal immunity by strengthening immune defenses in the upper airways. The goal is to prevent infections before they occur and reduce transmission.
A new approach to this old idea involves manipulating the genetic material of a weakened coronavirus to make it harder for cells to translate. This technique, called codon pair deoptimization, effectively shows the virus to the immune system without causing illness.
While promising results have been shown in hamster studies, more research is required before this vaccine can be tested in humans. The development process has been slow and challenging due to high costs and a lack of interest in vaccine development among some groups.
To combat Covid-19 effectively, researchers hope that future vaccines will be able to prevent infections at an early stage, reducing the risk of transmission.
In hamster experiments, two doses of this live but weakened vaccine stopped the virus from copying itself in the animals' upper airways, resulting in "sterilizing immunity" and preventing illness, a long-sought goal during the pandemic.
This breakthrough comes as other nasal vaccines are being tested in clinical trials or have already reached late-stage testing. However, experts caution that more work is needed before this vaccine can be widely used.
China and India have recently rolled out nasal vaccines given through the nasal tissues, but effectiveness data for these has not been published, leaving it unclear how well they may actually be working.
To combat the virus, researchers are focusing on boosting mucosal immunity by strengthening immune defenses in the upper airways. The goal is to prevent infections before they occur and reduce transmission.
A new approach to this old idea involves manipulating the genetic material of a weakened coronavirus to make it harder for cells to translate. This technique, called codon pair deoptimization, effectively shows the virus to the immune system without causing illness.
While promising results have been shown in hamster studies, more research is required before this vaccine can be tested in humans. The development process has been slow and challenging due to high costs and a lack of interest in vaccine development among some groups.
To combat Covid-19 effectively, researchers hope that future vaccines will be able to prevent infections at an early stage, reducing the risk of transmission.